Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
CareDx, Inc.Listing on record | Award | — | SEC | |
Intellia Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Intellia Therapeutics, Inc.Listing on record | Award | — | SEC | |
Kyverna Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Kyverna Therapeutics, Inc.Listing on record | Award | — | SEC | |
Intellia Therapeutics, Inc.Listing on record | Buy | $1.4M | SEC | |
CareDx, Inc.Listing on record | Award | — | SEC | |
Intellia Therapeutics, Inc.Listing on record | Award | — | SEC | |
Intellia Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Kyverna Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Kyverna Therapeutics, Inc.Listing on record | Award | — | SEC | |
UroGen Pharma Ltd.Listing on record | AwardD (derivative) | — | SEC | |
CareDx, Inc.Listing on record | AwardD (derivative) | — | SEC | |
CareDx, Inc.Listing on record | Award | — | SEC | |
CareDx, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Intellia Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Intellia Therapeutics, Inc.Listing on record | Award | — | SEC | |
Progyny, Inc.Listing on record | Award | — | SEC | |
Progyny, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Kyverna Therapeutics, Inc.Listing on record | OtherD (derivative) | — | SEC | |
Kyverna Therapeutics, Inc.Listing on record | Other | — | SEC | |
Kyverna Therapeutics, Inc.Listing on record | OtherD (derivative) | — | SEC | |
Kyverna Therapeutics, Inc.Listing on record | OtherD (derivative) | — | SEC | |
UroGen Pharma Ltd.Listing on record | AwardD (derivative) | — | SEC | |
UroGen Pharma Ltd.Listing on record | Award | $661.5K | SEC |